Medical Research
Foundation For Angelman Syndrome Therapeutics
AUSTIN, TX
Total revenue
$5.4M
Total expenses
$10.4M
Net assets
$40.2M
Grants received
$2.1M
112 grants
EIN
263160079
Tax year
2024
Mission
The foundation for angelman syndrome therapeutics (fast) is dedicated to finding a cure for angelman syndrome (as) and related disorders through the funding of an aggressive research agenda, education, awareness, and advocacy.
Programs
1 program
As is a rare disorder. The community of parents and caregivers of individuals with as rely heavily on social networking to become informed and seek advice and guidance on the challenges which the disorder presents. It is one of fast's objectives to educate, support, and strengthen this community.
Financials
FY 2024
Revenue
Expenses
People
16 listed
RYAN K FISCHER
CHIEF OPERATING OFICER
$286K
40 hrs/wk
ALANA NEWHOUSE
PRESIDENT/CEO
$245K
40 hrs/wk
KENA PEARSON
CHIEF FINANCIAL OFFICER
$233K
40 hrs/wk
MICHELE GOLOMBUSKI
CHIEF DEVELOPMENT OFFICER
$210K
40 hrs/wk
KARLY WARNER
DIRECTOR
—
5 hrs/wk
JOHN SCHLUETER
DIRECTOR
—
15 hrs/wk
KELLY DAVID
DIRECTOR
—
10 hrs/wk
BEN O'CONNOR
DIRECTOR
—
5 hrs/wk
RYAN JACOB
CHAIRPERSON
—
18 hrs/wk
LAUREN HOFFER
DIRECTOR
—
5 hrs/wk
NORA XU
DIRECTOR
—
5 hrs/wk
ALLYSON BERENT
CHIEF SCIENCE OFFICER
—
2 hrs/wk
ROY AZOUT
DIRECTOR
—
5 hrs/wk
MICHAEL HANRAHAN
VICE CHAIRPERSON AND TR
—
10 hrs/wk
GUY SHAPIRAL
TRESURER
—
15 hrs/wk
AMELIA BEATTY
SECRETARY
—
15 hrs/wk
Independent contractors
FAEGRE DRINKER BIDDLE & REATH LLP
ADVOCACY FIRM
VAN NESS CREATIVE STRATEGIES LLC
MARKETING
CHOATE HALL & STEWART LLP
LEGAL SERVICES
MAIDDY DUNIGAN
CONULTING
JESSICA DOBSON WEAVER
BOARD CONSULTANT
Grants received
Showing 112 of 112
Funded by
$2.1M from 46 funders · 112 grants · 2017–2024
$542K · 8 grants · 2017–2023
$250K · 1 grant · 2024
$236K · 6 grants · 2019–2024
$108K · 6 grants · 2018–2023
$100K · 4 grants · 2022–2024
$93K · 6 grants · 2018–2024
$85K · 2 grants · 2022–2023
$78K · 3 grants · 2020–2023